Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1993 May;77(5):315–316. doi: 10.1136/bjo.77.5.315

Impairment of tritan colour vision after initiation of treatment with zidovudine in patients with HIV disease or AIDS.

S A Geier 1, M Held 1, J R Bogner 1, U Kronawitter 1, T Berninger 1, V Klauss 1, F D Goebel 1
PMCID: PMC504513  PMID: 8318471

Full text

PDF
315

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Corey L., Fleming T. R. Treatment of HIV infection--progress in perspective. N Engl J Med. 1992 Feb 13;326(7):484–486. doi: 10.1056/NEJM199202133260710. [DOI] [PubMed] [Google Scholar]
  2. Fischl M. A., Richman D. D., Hansen N., Collier A. C., Carey J. T., Para M. F., Hardy W. D., Dolin R., Powderly W. G., Allan J. D. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group. Ann Intern Med. 1990 May 15;112(10):727–737. doi: 10.7326/0003-4819-112-10-727. [DOI] [PubMed] [Google Scholar]
  3. Graham N. M., Zeger S. L., Park L. P., Vermund S. H., Detels R., Rinaldo C. R., Phair J. P. The effects on survival of early treatment of human immunodeficiency virus infection. N Engl J Med. 1992 Apr 16;326(16):1037–1042. doi: 10.1056/NEJM199204163261601. [DOI] [PubMed] [Google Scholar]
  4. Hamilton J. D., Hartigan P. M., Simberkoff M. S., Day P. L., Diamond G. R., Dickinson G. M., Drusano G. L., Egorin M. J., George W. L., Gordin F. M. A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study. N Engl J Med. 1992 Feb 13;326(7):437–443. doi: 10.1056/NEJM199202133260703. [DOI] [PubMed] [Google Scholar]
  5. Hart W. M., Jr Acquired dyschromatopsias. Surv Ophthalmol. 1987 Jul-Aug;32(1):10–31. doi: 10.1016/0039-6257(87)90070-1. [DOI] [PubMed] [Google Scholar]
  6. Polten A., Fluharty A. L., Fluharty C. B., Kappler J., von Figura K., Gieselmann V. Molecular basis of different forms of metachromatic leukodystrophy. N Engl J Med. 1991 Jan 3;324(1):18–22. doi: 10.1056/NEJM199101033240104. [DOI] [PubMed] [Google Scholar]
  7. Quiceno J. I., Capparelli E., Sadun A. A., Munguia D., Grant I., Listhaus A., Crapotta J., Lambert B., Freeman W. R. Visual dysfunction without retinitis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1992 Jan 15;113(1):8–13. doi: 10.1016/s0002-9394(14)75745-9. [DOI] [PubMed] [Google Scholar]
  8. Volberding P. A., Lagakos S. W., Koch M. A., Pettinelli C., Myers M. W., Booth D. K., Balfour H. H., Jr, Reichman R. C., Bartlett J. A., Hirsch M. S. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. N Engl J Med. 1990 Apr 5;322(14):941–949. doi: 10.1056/NEJM199004053221401. [DOI] [PubMed] [Google Scholar]
  9. Whitcup S. M., Butler K. M., Caruso R., de Smet M. D., Rubin B., Husson R. N., Lopez J. S., Belfort R., Jr, Pizzo P. A., Nussenblatt R. B. Retinal toxicity in human immunodeficiency virus-infected children treated with 2',3'-dideoxyinosine. Am J Ophthalmol. 1992 Jan 15;113(1):1–7. doi: 10.1016/s0002-9394(14)75744-7. [DOI] [PubMed] [Google Scholar]
  10. Yarchoan R., Mitsuya H., Myers C. E., Broder S. Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides. N Engl J Med. 1989 Sep 14;321(11):726–738. doi: 10.1056/NEJM198909143211106. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES